Mergers & Acquisitions
M&A transactions move fast but can be delayed by never-ending regulation and compliance changes. Our Private Equity team delivers speed, innovation, and cost-savings to your transactions.
Our approach
Newfront’s expert team provides a strategic partnership by maintaining the same team from the letter of intent to the final liquidity.
A guide for a fast-moving future
We offer property & casualty, benefits, retirement, and human capital due diligence and placement services. We deliver detailed analysis of all areas of concern to move your transactions forward.
Due diligence
We produce comprehensive Insurance and Employee Benefits reports identifying cost-savings opportunities and key risk exposures.
Transaction liability
Our proprietary approach to RWI, Tax insurance, and Contingent Liability Insurance delivers premium savings, retention reductions, and enhanced policy language on future deals.
Portfolio companies
We aggregate key risk and insurance data across all portfolio companies and deliver digitized summaries of policies, renewals, coverages, premiums, and more.
The Newfront difference
Subject matter experts
We combine domain expertise with data-driven market insight to deliver real benefits to clients.
- Our M&A attorneys have large law firm experience and understand all the technical aspects of your transactions
- Our team have expertise brokering RWI, Tax, Contingent Liability and every form of transaction insurance
- Our deep relationships with key RWI insurers allow us to negotiate better policy terms, pricing, retention and coverage
- Our due diligence professionals operate as an extension of your team, to identify unique cost-savings opportunities
Leadership
Ted Dobos
Ted Dobos is the Private Equity Group Leader at Newfront. Ted oversees a talented team of dedicated advisors focused on mergers and acquisitions. With more than 30 years of experience, Ted brings expertise in leveraging insurance capital in M&A transactions.
Related articles
Reading the Risks for Biotech SPAC IPOs
Despite the disruptions, in both everyday life and the financial markets, caused by the COVID-19 pandemic that began in early 2020, IPO activity has remained strong. During the early stages of the pandemic, we witnessed a halt to public deal flow, However, over the past several months, we have seen the market come back strong.
IPOs: The Sparkle of SPAC
Companies have hardly slowed down their IPO plans in 2020, despite the temporary pause this spring when the COVID-19 pandemic began. In fact, 2020 is already outpacing last year in both the number of IPOs and the capital raised, some $200 billion so far.
SPAC, SPARC, or Spark?
If you have not turned on the news or have been hiding under a rock over the last year plus, you have likely missed out on the steady stream of SPAC’s (Special Purpose Acquisition Corporations) having gone public in 2020. 2021 really turned up the heat with over 300 SPAC’s IPO’ing in the first quarter […]